A Framework for the Definition and Interpretation of the Use of Surrogate Endpoints in Interventional Trials’

Oriana Ciani(Bocconi University), Rod S Taylor(University of Southern Denmark), Martin Offringa(Hospital for Sick Children), Philippa Davies(University of Bristol), Sylwia Bujkiewicz(University of Leicester), Laura Richert(Université de Bordeaux), Andrew Worrall, Vito Domenico Bruno(Istituto Clinico Sant'Ambrogio), Alain Amstutz(University Hospital of Basel), Alparslan Turan(Outcomes Research Consortium), Anthony Muchai Manyara(University of Bristol), Luca Bertolaccini(University of Milan), Joseph S. Ross(Yale University), Dalia Dawoud(Cairo University), Sarah Markham(King's College London), John H. Powers(Leidos (United States)), Christopher J. Weir(University of Edinburgh), Yousef Rezaei(Iran University of Medical Sciences), An‐Wen Chan(World Health Organization), Mario Ouwens(AstraZeneca (Sweden)), Declan Devane(Ollscoil na Gaillimhe – University of Galway), Gary S. Collins(NIHR Birmingham Biomedical Research Centre), Jane Blazeby(University Hospitals Bristol NHS Foundation Trust), Falk Schwendicke(LMU Klinikum), Derek Stewart, Robin Christiansen(Frederiksberg Hospital), Lucio Marinelli(Martin University), Nancy J. Butcher(University of Toronto), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Amber Young(University of Bristol), Asbjørn Hróbjartsson(University of Southern Denmark), Ray Harris, Marissa Lassere(UNSW Sydney), Christina Danielli Coelho de Morais Faria(Universidade Federal de Minas Gerais), Larisa G. Tereshchenko(Cleveland Clinic Lerner College of Medicine)
SSRN Electronic Journal
January 1, 2023
Cited by 0


Related Papers